BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23315045)

  • 1. Breast cancer diagnosis from screening in trinidad and tobago: opportunities for cancer prevention.
    D Joseph M; Thorpe L; Annandsingh C; Laquis G; Lee Young J; Kwasniewski J; Lee R; Taioli E
    J Immigr Minor Health; 2014 Jun; 16(3):409-15. PubMed ID: 23315045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes.
    Gao Y; Goldberg JE; Young TK; Babb JS; Moy L; Heller SL
    Radiology; 2019 Nov; 293(2):282-291. PubMed ID: 31526252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-stage breast cancer screening in the developing world.
    Batsis C
    World J Surg; 2011 Mar; 35(3):698-9. PubMed ID: 20857103
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
    Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
    Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Breast Density Implications and Breast Cancer Screening.
    Lian J; Li K
    Clin Breast Cancer; 2020 Aug; 20(4):283-290. PubMed ID: 32334975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Performance of Synthesized Two-dimensional Mammography Combined with Tomosynthesis in a Large Screening Population.
    Aujero MP; Gavenonis SC; Benjamin R; Zhang Z; Holt JS
    Radiology; 2017 Apr; 283(1):70-76. PubMed ID: 28221096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderation effect of mammography screening among women with multiple chronic conditions.
    Hsieh HM; Shen CT; Chen LS; Chen FM; Yeh SC
    Sci Rep; 2022 Feb; 12(1):2303. PubMed ID: 35145157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.
    Beaber EF; Sprague BL; Tosteson ANA; Haas JS; Onega T; Schapira MM; McCarthy AM; Li CI; Herschorn SD; Lehman CD; Wernli KJ; Barlow WE
    J Womens Health (Larchmt); 2019 Aug; 28(8):1051-1059. PubMed ID: 30481098
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and diagnostic outcome of bilateral recall at screening mammography.
    Lameijer JRC; Nederend J; Voogd AC; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2021 Jan; 148(1):48-56. PubMed ID: 32621785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.